141 related articles for article (PubMed ID: 28477016)
1. E6AP promotes prostate cancer by reducing p27 expression.
Raghu D; Paul PJ; Gulati T; Deb S; Khoo C; Russo A; Gallo E; Blandino G; Chan AL; Takano E; Sandhu SK; Fox SB; Williams S; Haupt S; Gamell C; Haupt Y
Oncotarget; 2017 Jun; 8(26):42939-42948. PubMed ID: 28477016
[TBL] [Abstract][Full Text] [Related]
2. Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP.
Paul PJ; Raghu D; Chan AL; Gulati T; Lambeth L; Takano E; Herold MJ; Hagekyriakou J; Vessella RL; Fedele C; Shackleton M; Williams ED; Fox S; Williams S; Haupt S; Gamell C; Haupt Y
Oncogene; 2016 Dec; 35(48):6235-6245. PubMed ID: 27641331
[TBL] [Abstract][Full Text] [Related]
3. Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer.
Gamell C; Gulati T; Levav-Cohen Y; Young RJ; Do H; Pilling P; Takano E; Watkins N; Fox SB; Russell P; Ginsberg D; Monahan BJ; Wright G; Dobrovic A; Haupt S; Solomon B; Haupt Y
Sci Signal; 2017 Jan; 10(461):. PubMed ID: 28074012
[TBL] [Abstract][Full Text] [Related]
4. Proteotranscriptomic Measurements of E6-Associated Protein (E6AP) Targets in DU145 Prostate Cancer Cells.
Gulati T; Huang C; Caramia F; Raghu D; Paul PJ; Goode RJA; Keam SP; Williams SG; Haupt S; Kleifeld O; Schittenhelm RB; Gamell C; Haupt Y
Mol Cell Proteomics; 2018 Jun; 17(6):1170-1183. PubMed ID: 29463595
[TBL] [Abstract][Full Text] [Related]
5. LncRNA GAS5 Inhibits Cellular Proliferation by Targeting P27
Luo G; Liu D; Huang C; Wang M; Xiao X; Zeng F; Wang L; Jiang G
Mol Cancer Res; 2017 Jul; 15(7):789-799. PubMed ID: 28396462
[TBL] [Abstract][Full Text] [Related]
6. p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer.
Zhao H; Lu Z; Bauzon F; Fu H; Cui J; Locker J; Zhu L
Oncogene; 2017 Jan; 36(1):60-70. PubMed ID: 27181203
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery.
Rodríguez-Ubreva FJ; Cariaga-Martinez AE; Cortés MA; Romero-De Pablos M; Ropero S; López-Ruiz P; Colás B
Oncogene; 2010 Jan; 29(3):345-55. PubMed ID: 19838216
[TBL] [Abstract][Full Text] [Related]
8. Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.
Su S; Minges JT; Grossman G; Blackwelder AJ; Mohler JL; Wilson EM
J Biol Chem; 2013 Aug; 288(34):24809-24. PubMed ID: 23853093
[TBL] [Abstract][Full Text] [Related]
9. COP1 enhances ubiquitin-mediated degradation of p27Kip1 to promote cancer cell growth.
Choi HH; Phan L; Chou PC; Su CH; Yeung SC; Chen JS; Lee MH
Oncotarget; 2015 Aug; 6(23):19721-34. PubMed ID: 26254224
[TBL] [Abstract][Full Text] [Related]
10. Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death.
Birch SE; Kench JG; Takano E; Chan P; Chan AL; Chiam K; Veillard AS; Stricker P; Haupt S; Haupt Y; Horvath L; Fox SB
Ann Oncol; 2014 Dec; 25(12):2392-2397. PubMed ID: 25231954
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of Skp2 is correlated with p27-associated cell cycle arrest induced by phenylacetate in human prostate cancer cells.
Shibahara T; Onishi T; Franco OE; Arima K; Sugimura Y
Anticancer Res; 2005; 25(3B):1881-8. PubMed ID: 16158921
[TBL] [Abstract][Full Text] [Related]
12. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
Levitt RJ; Zhao Y; Blouin MJ; Pollak M
Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
[TBL] [Abstract][Full Text] [Related]
13. Correlation of constitutive photomorphogenic 1 (COP1) and p27 tumor suppressor protein expression in ovarian cancer.
Ko EJ; Oh YL; Kim HY; Eo WK; Kim H; Kim KH; Koh SB; Ock MS; Choi YH; Kim A; Choi HH; Park EJ; Cha HJ
Genes Genomics; 2019 Aug; 41(8):879-884. PubMed ID: 31028655
[TBL] [Abstract][Full Text] [Related]
14. p27(Kip1) signaling: Transcriptional and post-translational regulation.
Hnit SS; Xie C; Yao M; Holst J; Bensoussan A; De Souza P; Li Z; Dong Q
Int J Biochem Cell Biol; 2015 Nov; 68():9-14. PubMed ID: 26279144
[TBL] [Abstract][Full Text] [Related]
15. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
[TBL] [Abstract][Full Text] [Related]
16. E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesis.
Wolyniec K; Shortt J; de Stanchina E; Levav-Cohen Y; Alsheich-Bartok O; Louria-Hayon I; Corneille V; Kumar B; Woods SJ; Opat S; Johnstone RW; Scott CL; Segal D; Pandolfi PP; Fox S; Strasser A; Jiang YH; Lowe SW; Haupt S; Haupt Y
Blood; 2012 Jul; 120(4):822-32. PubMed ID: 22689861
[TBL] [Abstract][Full Text] [Related]
17. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
[TBL] [Abstract][Full Text] [Related]
18. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Circular RNA Itchy E3 Ubiquitin Protein Ligase Inhibits Cell Proliferation and Promotes Cell Apoptosis Through Targeting MiR-197 in Prostate Cancer.
Yuan Y; Chen X; Huang E
Technol Cancer Res Treat; 2019; 18():1533033819886867. PubMed ID: 31694481
[TBL] [Abstract][Full Text] [Related]
20. Skp2 is associated with paclitaxel resistance in prostate cancer cells.
Yang Y; Lu Y; Wang L; Mizokami A; Keller ET; Zhang J; Fu J
Oncol Rep; 2016 Jul; 36(1):559-66. PubMed ID: 27175797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]